Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SOMATOSTATIN ANALOG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 919 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Orsi, P; Guatti-Zuliani, C; Okolicsanyi, L
      Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract

      DIGESTIVE AND LIVER DISEASE
    2. Kotzampassi, K; Koufogiannis, D; Eleftheriadis, E
      Sustained reduction of portal pressure by administration of octreotide-LARin portal hypertensive rats

      HEPATOLOGY RESEARCH
    3. Orlandi, F; Caraci, P; Mussa, A; Saggiorato, E; Pancani, G; Angeli, A
      Treatment of medullary thyroid carcinoma: an update

      ENDOCRINE-RELATED CANCER
    4. Acerini, L; Williams, M; Dunger, B
      Puberty and type 1 diabetes

      DIABETES & METABOLISM
    5. Anel, RML; Sheagren, JN
      Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents

      CLINICAL INFECTIOUS DISEASES
    6. Frohman, LA
      Pituitary tumors in pregnancy

      ENDOCRINOLOGIST
    7. Brouland, JP; Manivet, P; Brocheriou-Spelle, I; Wassef, M; Le Bodic, MF; Lavergne, A; Launay, JM
      Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: Expression of the serotonin-2B receptor bythe neuroendocrine component

      ENDOCRINE PATHOLOGY
    8. Gali, H; Sieckman, GL; Hoffman, TJ; Owen, NK; Chin, DT; Forte, LR; Volkert, WA
      In vivo evaluation of an In-111-labeled ST-peptide analog for specific-targeting of human colon cancers

      NUCLEAR MEDICINE AND BIOLOGY
    9. Hoffman, TJ; Quinn, TP; Volkert, WA
      Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells

      NUCLEAR MEDICINE AND BIOLOGY
    10. Amartey, JK; Parhar, RS; Al-Jammaz, I
      Synthesis and preliminary evaluation of Tc-99m-labeled somatostatin analog(RC-160) using "3+1" mixed ligand approach

      NUCLEAR MEDICINE AND BIOLOGY
    11. Bugaj, JE; Erion, JL; Johnson, MA; Schmidt, MA; Srinivasan, A
      Radiotherapeutic efficacy of Sm-153-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats

      NUCLEAR MEDICINE AND BIOLOGY
    12. Iznaga-Escobar, N
      Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors - a review of radiolabeling characteristics, quality control and in vitro stability studies

      APPLIED RADIATION AND ISOTOPES
    13. Sabba, C; Buonamico, P; Vendemiale, G; Berardi, E; Antonica, G; Palmieri, V; Merkel, C; Palasciano, G
      Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    14. Waldherr, C; Pless, M; Maecke, HR; Haldemann, A; Mueller-Brand, J
      The clinical value of [Y-90-DOTA]-D-Phe(1)-Tyr(3)-octreotide (Y-90-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

      ANNALS OF ONCOLOGY
    15. Zidan, J; Haim, N; Beny, A; Stein, M; Gez, E; Kuten, A
      Octreotide in the treatment of severe chemotherapy-induced diarrhea

      ANNALS OF ONCOLOGY
    16. Kaltsas, GA; Mukherjee, JJ; Grossman, AB
      The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours

      ANNALS OF ONCOLOGY
    17. Vantus, T; Keri, G; Krivickiene, Z; Valius, M; Stetak, A; Keppens, S; Csermely, P; Bauer, PI; Bokonyi, G; Declercq, W; Vandenabeele, P; Merlevede, W; Vandenheede, JR
      The somatostatin analogue TT-232 induces apoptosis in A431 cells - Sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinases

      CELLULAR SIGNALLING
    18. Ben-Shlomo, A; Melmed, S
      Acromegaly

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    19. Abe, T; Ludecke, DK
      Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    20. Bogolioubov, A; Keefe, DL; Groeger, JS
      Circulatory shock

      CRITICAL CARE CLINICS
    21. Cascinu, S; Del Ferro, E; Ligi, M; Staccioli, MP; Giordani, P; Catalano, V; Agostinelli, R; Muretto, P; Catalano, G
      Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients

      CANCER INVESTIGATION
    22. Thanou, M; Verhoef, JC; Verheijden, JHM; Junginger, HE
      Intestinal absorption of octreotide using trimethyl chitosan chloride: Studies in pigs

      PHARMACEUTICAL RESEARCH
    23. Hastier, P
      Can post-ERCP acute pancreatitis be predicted and prevented?

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    24. Heyries, L
      ERCP-induced pancreatitis: risk factors and prophylactic treatment

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    25. Diez, JJ; Iglesias, P; Gomez-Pan, A
      Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    26. Attanasio, R; Barausse, M; Cozzi, R
      GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    27. Ciotta, L; De Leo, V; Farina, M; Parfumi, C; La Marca, A; Cianci, A
      Endocrine and metabolic effects of insulin sensitizers in the treatment ofpatients with polycystic ovary syndrome and hyperinsulinaemia

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    28. Aniszewski, JP; Young, WF; Thompson, GB; Grant, CS; van Heerden, JA
      Cushing syndrome due to ectopic adrenocorticotropic hormone secretion

      WORLD JOURNAL OF SURGERY
    29. Skogseid, B
      Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids

      WORLD JOURNAL OF SURGERY
    30. Rideout, DJ; Graham, MM
      Buttock granulomas - A consequence of intramuscular injection of sandostatin detected by In-111 octreoscan

      CLINICAL NUCLEAR MEDICINE
    31. Kwekkeboom, DJ; Bakker, WH; Kooij, PPM; Konijnenberg, MW; Srinivasan, A; Erion, JL; Schmidt, MA; Bugaj, JL; de Jong, M; Krenning, EP
      [Lu-177-DOTA(0),Tyr(3)]octreotate: comparison with [In-111-DTPA(0)]octreotide in patients

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    32. Cybulla, M; Weiner, SM; Otte, A
      End-stage renal disease after treatment with Y-90-DOTATOC

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    33. Ortuno, FM; Alfonso, AMP; Martinez, JGM; Escribano, JRD; Paya, VEC; Rocamora, JP; Garri, FS
      Biventricular impairment in diastolic function in acromegaly

      REVISTA ESPANOLA DE CARDIOLOGIA
    34. Minniti, G; Moroni, C; Jaffrain-Rea, ML; Esposito, V; Santoro, A; Affricano, C; Cantore, G; Tamburrano, G; Cassone, R
      Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients

      CLINICAL ENDOCRINOLOGY
    35. Fassnacht, M; Capeller, B; Arlt, W; Steck, T; Allolio, B
      Octreotide LAR (R) treatment throughout pregnancy in an acromegalic woman

      CLINICAL ENDOCRINOLOGY
    36. Colao, A; Spiezia, S; Cerbone, G; Pivonello, R; Marzullo, P; Ferone, D; Di Somma, C; Assanti, AP; Lombardi, G
      Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly

      CLINICAL ENDOCRINOLOGY
    37. Colao, A; Marzullo, P; Di Somma, C; Lombardi, G
      Growth hormone and the heart

      CLINICAL ENDOCRINOLOGY
    38. Andersen, M; Bjerre, P; Schroder, HD; Edal, A; Hoilund-Carlsen, PF; Pedersen, PH; Hagen, C
      In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas

      CLINICAL ENDOCRINOLOGY
    39. Gonzalez, D; Elizondo, BJ; Haslag, S; Buchanan, G; Burdick, JS; Guzzetta, PC; Hicks, BA; Andersen, JM
      Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    40. Lee, LF; Guan, JL; Qiu, Y; Kung, HJ
      Neuropeptide-induced androgen independence in prostate cancer cells: Rolesof nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

      MOLECULAR AND CELLULAR BIOLOGY
    41. Pereira, SP; Hussaini, SH; Murphy, GM; Wass, JAH; Dowling, RH
      Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    42. Testoni, PA; Bagnolo, F; Andriulli, A; Bernasconi, G; Crotta, S; Lella, F; Lomazzi, A; Minoli, G; Natale, C; Prada, A; Toti, GL; Zambelli, A
      Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    43. Moschetta, A; Stolk, MFJ; Rehfeld, JF; Portincasa, P; Slee, PHTJ; Koppeschaar, HPF; Van Erpecum, KJ; Vanberge-Henegouwen, GP
      Severe impairment of postprandial cholecystokinin release and gall-bladderemptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    44. Ciotta, L; Calogero, AE; Farina, M; De Leo, V; La Marca, A; Cianci, A
      Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance

      HUMAN REPRODUCTION
    45. Bruskin, A; Tolmachev, V; Westlin, JE; Lundqvist, H
      Separation of two labeled components of [In-111]-OctreoScan by HPLC

      JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
    46. Jensen, JAG; Carroll, RE; Benya, RV
      The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer

      PEPTIDES
    47. Bruttomesso, D; Fongher, C; Silvestri, B; Barberio, S; Marescotti, MC; Iori, E; Valerio, A; Crazzolara, D; Pianta, A; Tiengo, A; Del Prato, S
      Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients

      DIABETES RESEARCH AND CLINICAL PRACTICE
    48. Stoll, GH; Nimmerfall, F; Acemoglu, M; Bodmer, D; Bantle, S; Muller, I; Mahl, A; Kolopp, M; Tullberg, K
      Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents

      JOURNAL OF CONTROLLED RELEASE
    49. Jane, JA; Thapar, K; Laws, ER
      Acromegaly: historical perspectives and current therapy

      JOURNAL OF NEURO-ONCOLOGY
    50. Sanno, N; Teramoto, A; Osamura, RY
      Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment

      JOURNAL OF NEURO-ONCOLOGY
    51. Waldherr, C; Schumacher, T; Pless, M; Crazzolara, A; Maecke, HR; Nitzsche, EU; Haldemann, A; Mueller-Brand, J
      Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using [Y-90]-DOTA-D-Phe(1)-Tyr(3)-octreotide: a pilot study

      NUCLEAR MEDICINE COMMUNICATIONS
    52. Van de Wiele, C; Dumont, F; Van Belle, S; Slegers, G; Peers, SH; Dierckx, RA
      Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?

      NUCLEAR MEDICINE COMMUNICATIONS
    53. Engelbach, M; Heusel, CP; Kriegsmann, J; Both, S; Walgenbach, S
      Drug therapy in carcinoid tumors of the gastrointestinal tract

      ZENTRALBLATT FUR CHIRURGIE
    54. Orsenigo, R; Gatti, S; Latham, L; Trezza, P; Marelli, O
      FK506 and SMS 201-995: Effect on heterotopic heart transplantation in rats

      TRANSPLANTATION PROCEEDINGS
    55. Hoegerle, S; Altehoefer, C; Ghanem, N; Koehler, G; Waller, CF; Scheruebl, H; Moser, E; Nitzsche, E
      Whole-body F-18 dopa PET for detection of gastrointestinal carcinoid tumors

      RADIOLOGY
    56. Li-Ling, J; Irving, M
      Therapeutic value of octreotide for patients with severe dumping syndrome - a review of randomised controlled trials

      POSTGRADUATE MEDICAL JOURNAL
    57. Alderton, F; Humphrey, PPA; Sellers, LA
      High-intensity p38 kinase activity is critical for p21(cip1) induction andthe antiproliferative function of G(i) protein-coupled receptors

      MOLECULAR PHARMACOLOGY
    58. Wang, JR; Zheng, H; Hauer-Jensen, M
      Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor beta (TGF-beta) overexpression, and collagen accumulation in irradiated rat intestine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    59. Caron, P; Arlot, S; Bauters, C; Chanson, P; Kuhn, JM; Pugeat, M; Marechaud, R; Teutsch, C; Vidal, E; Sassano, P
      Efficacy of the long-acting octreotide formulation (Octreotide-Lar) in patients with thyrotropin-secreting pituitary adenomas

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    60. Colao, A; Cuocolo, A; Marzullo, P; Nicolai, E; Ferone, D; Morte, AMD; Pivonello, R; Salvatore, M; Lombardi, G
      Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    61. Losa, M; Ciccarelli, E; Mortini, P; Barzaghi, R; Gaia, D; Faccani, G; Papotti, M; Mangili, F; Terreni, MR; Camanni, F; Giovanelli, M
      Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    62. Lewis, JS; Wang, M; Laforest, R; Wang, F; Erion, JL; Bugaj, JE; Srinivasan, A; Anderson, CJ
      Toxicity and dosimetry of Lu-177-DOTA-Y3-octreotate in a rat model

      INTERNATIONAL JOURNAL OF CANCER
    63. Boehm, BO; Lang, GK; Jehle, PM; Feldmann, B; Lang, GE
      Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy

      HORMONE AND METABOLIC RESEARCH
    64. Cannavo, S; Squadrito, S; Curto, L; Almoto, B; Trimarchi, F
      Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma

      HORMONE AND METABOLIC RESEARCH
    65. Gonzalez-Pinto, I; Gonzalez, EM
      Optimising the treatment of upper gastrointestinal fistulae

      GUT
    66. Budzynska, A; Marek, T; Nowak, A; Kaczor, R; Nowakovska-Dulawa, E
      A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis

      ENDOSCOPY
    67. Connolly, HM; Schaff, HV; Mullany, CJ; Rubin, J; Abel, MD; Pellikka, PA
      Surgical management of left-sided carcinoid heart disease

      CIRCULATION
    68. Dean, A
      The palliative effects of octreotide in cancer patients

      CHEMOTHERAPY
    69. Vainas, IG
      Octreotide in the management of hormone-refractory prostate cancer

      CHEMOTHERAPY
    70. Bussolati, G; Chinol, M; Chini, B; Nacca, A; Cassoni, P; Paganelli, G
      In-111-labeled 1,4,7,10-tetraazacyclododecane-N,N',N''N'''-tetraacetic acid-Lys(8)-vasotocin: A new powerful radioligand for oxytocin receptor-expressing tumors

      CANCER RESEARCH
    71. Vitale, G; Caraglia, M; Ciccarelli, A; Lupoli, G; Abbruzzese, A; Tagliaferri, P; Lupoli, G
      Current approaches and perspectives in the therapy of medullary thyroid carcinoma

      CANCER
    72. Kinney, MAO; Warner, ME; Nagorney, DM; Rubin, J; Schroeder, DR; Maxson, PM; Warner, MA
      Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours

      BRITISH JOURNAL OF ANAESTHESIA
    73. Shepherd, CM; Schaus, KA; Vogel, HJ; Juffer, AH
      Molecular dynamics study of peptide-bilayer adsorption

      BIOPHYSICAL JOURNAL
    74. Stetak, A; Csermely, P; Ullrich, A; Keri, G
      Physical and functional interactions between protein tyrosine phosphatase alpha, PI 3-kinase, and PKC delta

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    75. Nehra, V; Camilleri, M; Burton, D; Oenning, L; Kelly, DG
      An open trial of octreotide long-acting release in the management of shortbowel syndrome

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    76. Liote, F; Orcel, P
      Osteoarticular disorders of endocrine origin

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    77. Herlihy, OM; Perros, P
      Elevated serum growth hormone in a patient with Type 1 diabetes: a diagnostic dilemma

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    78. Ercan, MT; Caglar, M
      Therapeutic radiopharmaceuticals

      CURRENT PHARMACEUTICAL DESIGN
    79. Brickman, WJ; Silverman, BL
      Cardiovascular effects of growth hormone

      ENDOCRINE
    80. Anderson, CJ; Lewis, JS
      Radiopharmaceuticals for targeted radiotherapy of cancer

      EXPERT OPINION ON THERAPEUTIC PATENTS
    81. Ferone, D; Colao, A; van de Lely, AJ; Lamberts, SWJ
      Pharmacotherapy or surgery as primary treatment for acromegaly?

      DRUGS & AGING
    82. Oberg, K
      State of the art and future prospects in the management of neuroendocrine tumors

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    83. Cutler, CS; Smith, CJ; Ehrhardt, GJ; Tyler, TT; Jurisson, SS; Deutsch, E
      Current and potential therapeutic uses of lanthanide radioisotopes

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    84. Burch, PA; Block, M; Schroeder, G; Kugler, JW; Sargent, DJ; Braich, TA; Mailliard, JA; Michalak, JC; Hatfield, AK; Wright, K; Kuross, SA
      Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracilor 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A north central cancer treatment group study

      CLINICAL CANCER RESEARCH
    85. Beckman, RA; Siden, R; Yanik, GA; Levine, JE
      Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    86. Usenmez, T; Yildiz, O; Oktenli, C; Ozgurtas, T; Kutlu, M
      Octreotide administration in diabetic rats: effects on renal function and morphology

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    87. McDougall, IR
      Systemic radiation therapy with unsealed radionuclides

      SEMINARS IN RADIATION ONCOLOGY
    88. Vaidyanathan, G; Affleck, D; Welsh, P; Srinavasan, A; Schmidt, M; Zalutsky, MR
      Radioiodination and astatination of octreotide by conjugation labeling

      NUCLEAR MEDICINE AND BIOLOGY
    89. Bakke, I; Sandvik, AK; Waldum, HL
      Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia

      JOURNAL OF MOLECULAR ENDOCRINOLOGY
    90. Heppeler, A; Froidevaux, S; Eberle, AN; Maecke, HR
      Receptor targeting for tumor localisation and therapy with radiopeptides

      CURRENT MEDICINAL CHEMISTRY
    91. Burggraaf, J; Schoemaker, RC; Lentjes, EGWM; Cohen, AF
      Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    92. Corleto, VD; Angeletti, S; Schillaci, O; Marignani, M; Caratozzolo, M; Panzuto, F; Annibale, B; Delle Fave, G
      Long-term octreotide treatment of metastatic carcinoid tumor

      ANNALS OF ONCOLOGY
    93. Teno, S; Nakajima-Uto, Y; Nagai, K; Shimizu-Saitoh, M; Ozu, H; Omori, Y; Takizawa, T
      Treatment with alpha-glucosidase inhibitor for severe reactive hypoglycemia: A case report

      ENDOCRINE JOURNAL
    94. Kornblau, S; Benson, AB; Catalano, R; Champlin, RE; Engelking, C; Field, M; Ippoliti, C; Lazarus, HM; Mitchell, E; Rubin, J; Stiff, PJ; Vokes, E; Wadler, S
      Management of cancer treatment-related diarrhea: Issues and therapeutic strategies

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    95. Claure, RE; Drover, DD; Haddow, GR; Esquivel, CO; Angst, MS
      Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management

      CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
    96. Verhelst, JA; Pedroncelli, AM; Abs, R; Montini, M; Vandeweghe, M; Albani, G; Maiter, D; Pagani, MD; Legros, JJ; Gianola, D; Bex, M; Poppe, K; Mockel, J; Pagani, G
      Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    97. Kwekkeboom, DJ; van Hagen, PM; Krenning, EP
      Refractory immune-mediated and haematological diseases: candidates for peptide receptor radiotherapy?

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    98. Nelson, JB; Carducci, MA
      Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer

      CANCER INVESTIGATION
    99. Schott, M; Scherbaum, WA; Feldkamp, J
      Medical therapy of endocrine carcinomas. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids und other carcinomas

      MEDIZINISCHE KLINIK
    100. Turhal, NS; Bruckner, HW
      Pancreatic duct cell carcinoma with positive In-111 octreotide uptake

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 00:02:19